Benth. is traditionally used in South Africa for treating stomach aches, nausea, vomiting and meningitis. Bioassay-guided fractionation of the ethyl acetate extract of the plant led to the isolation of two known compounds, parvifloron D and parvifloron F, neither of which has been previously reported for this species. The compounds exhibited minimum inhibitory concentrations of 15.6 and 31.2 µg/mL, respectively against Listeria monocytogenes, whereas the values against a drug-sensitive strain of Mycobacterium tuberculosis were 190 and 95 µg/mL, respectively. The ethyl acetate extract of P. ecklonii and its isolated compounds were tested for their activity on tyrosinase inhibition. The concentration at which half the tyrosinase activity was inhibited (IC 50 ) by the extract was found to be 61.7 ± 2.7 µg/mL. The antibacterial activity of the extract and its isolated compounds correlates with the traditional use of the plant for various ailments such as stomach aches, diarrhea and skin diseases. The fifty percent inhibitory concentrations of parvifloron D and parvifloron F against vero cell lines were found to be 2.9 µg/mL and 1.6 µg/mL, respectively. This is the first report of the bioactivity of P. ecklonii extract and its constituents.
Parvifloron D (1) was isolated from fraction IV, and parvifloron F (2) from fraction V. The identity of these known compounds was readily established by comparison of their spectral properties ( 1 H-and 13 C NMR ) with those reported [1a,3b] . Parvifloron D was previously isolated from P. strigosus Benth.
[3b], and parvifoloron F from P. nummularius Briq. [1a] ; the latter was found to have anti-oxidative activity. Neither parvifloron D nor F have been reported for P. ecklonii up to now. Other compounds that have been previously isolated from P. ecklonii are ekclonoquinone A, ecklonoquinone B, 4',5dihydroxy-6,7-dimethoxy-flavanone, and nepetoidins A and B [4] . Nepetoidins A and B have been reported to exhibit antifungal activity against Aspergillus niger [4] . Besides these data, little is known about the constituents of this plant.
The MICs of compounds 1 and 2 against L. monocytogenes were 15.6 µg/mL and 31.2 µg/mL, respectively. These results are comparable to the 125 µg/mL that was obtained for both the essential oil of Heracleum sphondylium subsp. ternatum and its main component, 1-octanol against L. monocytogenes [5a] . The MICs of P. ecklonii ethyl acetate extract against Gram-positive and Gram-negative bacteria species ranged from 125.0 to 1000.0 µg/mL (Table 1) .
Compounds 1 and 2 were found to be active at a low concentration of 31.3 µg/mL against some of the bacterial species tested. The MIC of P. cylindraceus oil against E. coli was reported as 125 µg/mL [5b], which is similar to that obtained in the present study. P. ecklonii is traditionally used to treat skin infections in Zimbabwe [1b] and this could be possibly linked to the antibacterial activity of parviflorons D and F against S. aureus. Plectranthus species have been traditionally used in folk medicine to treat digestive problems and stomach ache [1b] . The activity of P. ecklonii against E. coli observed in the present study justifies the use of this species in traditional medicine for the treatment of gastro-enteric infections.
The antimycobacterial properties of the investigated crude extract of P. ecklonii and its isolated compounds are shown in Table 1 . The MIC of 95 µg/mL exhibited by compound 2 is similar to the reports on the inhibitory activity of shinanolone and mamegakinone against Mycobacterium tuberculosis H37RV strain [6a]. The MIC of the P. ecklonii crude extract against M. tuberculosis H37RV strain (380 µg/mL) was found to be comparable to those of previous studies of a number of Helichrysum species that exhibited MICs of 0.5 mg/mL [5b] .
A number of other plants such as Pelargonium reniforme, P. sidoides, Achillea millefolium, Ageratum corimbosum, and Anoda cristata have been reported to have MIC values ≥ 1.0 mg/mL [6b,7] . The crude extract of P. ecklonii exhibited an MIC of 78.1 µg/mL against a non-pathogenic Mycobacterium species i.e. M. smegmatis. Our results are similar to previous finding for extracts of Mentha piperita and Cinnamomum zeylanicum, which gave a MIC of 500.0 µg/mL against M. smegmatis [8a] .
Compound 2 also showed good antimycobacterial activity against M. smegmatis at a concentration of 39.1 µg/mL (MIC).
The ethyl acetate extract of P. ecklonii and its isolated compounds were tested for their activity on tyrosinase inhibition. The concentration of plant 
Isolation of bioactive compounds:
The leaves of P. ecklonii (550 g) were extracted with ethyl acetate (2 x 2L) for 48 hours, at room temperature (± 25°C). The ethyl acetate extract was filtered and concentrated to dryness using Rotavapor. The total extract (110 g) was subjected to silica gel column chromatography (CC, size 7 cm x 120 cm) using hexane/ethyl acetate mixtures of increasing polarity (0 to 100%). Similar fractions were combined based on the TLC profile into 5 main fractions. The five fractions were tested against L. monocytogenes and it was found that 2 fractions, fraction IV and V exhibited good antilisterial activity. Fraction V (2.9 g) was subjected to Sephadex LH-20 column using dichloromethane/ methanol mixtures (100% dichloromethane, 99%, 2%, 3%) (v/v) as eluent to give compound 1 (yield 2.31 g, 0.42%). Fraction IV (2.5 g), under the same conditions gave 2 (yield 937 mg, 0.17%).
Activity of samples against Listeria monocytogenes and other bacteria:
The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) determination were done as stated previously against L. monocytogenes (LMG 2163) [9a,9b] . The concentration of crude extract and compounds tested ranged from 7.81 to 1000 µg/mL. The plates were sealed and incubated at 37ºC for 24 h. The MIC of the samples was determined by adding 40 µL of (0.2 mg/mL) p-iodonitrotetrazolium violet (INT) (Sigma-Aldrich, South Africa) to microtitre wells and re-incubated at 37ºC for 1 h [7,9a] to indicate the presence of bacterial growth (pink color) or inhibition of bacterial growth (no color). The MIC was defined as the lowest concentration of the extract that caused no color change and showed complete inhibition of bacterial growth. The minimum bactericidal concentration (MBC) was determined by transferring 50 µL of the sample from the wells which did not show bacterial growth during MIC assays (without INT), to 150 µL of freshly prepared broth. The plates were re-incubated at 37ºC for 48 h. The MBC was regarded as the lowest concentration which did not give rise to a color change after INT was added as described above in the MIC assay. Erythromycin was used as a drug control for L. monocytogenes.
Each culture of Staphylococcus aureus (ATCC 12600), Escherichia coli (ATCC 25922), Enterococcus faecalis (ATCC 29212), and Pseudomonas aeruginosa (ATTCC 27853) was transferred onto a nutrient agar slant and the culture was recovered for testing by growing on a nutrient broth (BIOLAB, South Africa) for 24 h at 37ºC. Ciprofloxacin was used as a drug control. The MIC and MBC were determined as stated above.
Antimycobacterial bioassay:
Mycobacterium smegmatis (MC 2 155) and a drug susceptible strain of M. tuberculosis H37Rv (ATCC 27264) were acquired from American Type, MD, USA Culture Collection. A microplate dilution method was used for the testing of the samples against M. smegmatis in 96-well microtiter plates according to [9c] . For susceptibility testing of M. tuberculosis, the radiometric respiratory technique using the BACTEC 460 system (Becton Dickinson Diagnostic Instrument, Sparks, MD) was used, as described previously [10a-10c] . The crude extracts and purified compounds 1 and 2 were dissolved in 10% DMSO in sterile 7H9 broth to obtain a stock concentration of 1.250 mg/mL. The final concentration ranged from 9.76-312.50 μg/mL.
